Literature DB >> 17293187

Prevalence and extent of obstructive coronary artery disease in patients with zero or low calcium score undergoing 64-slice cardiac multidetector computed tomography for evaluation of a chest pain syndrome.

Ronen Rubinshtein1, Tamar Gaspar, David A Halon, Jacob Goldstein, Nathan Peled, Basil S Lewis.   

Abstract

We examined the extent of coronary artery disease (CAD) on 64-slice contrast-enhanced multidetector computed tomography in patients who underwent investigation of a chest pain syndrome who had a zero or low coronary calcium score (CS). In 668 consecutive patients with chest pain syndromes (39% with acute presentation, 61% with long-term presentation) who underwent cardiac multidetector computed tomography, we assessed prevalence and severity of coronary stenoses (>or=1 coronary artery stenosis with >or=50% luminal narrowing) in 231 patients (54 +/- 12 years of age, 45% women) with a 0 (n = 125) or low (n = 106) coronary CS. Obstructive (>or=50% lesion) CAD was present in 27 of 231 patients, in 9 of 125 patients (7%) with a 0 CS, in 18 of 106 (17%) with a low CS (1 to 100), and in 14 of 90 patients (16%) with an acute presentation and 13 of 141 patients (9%) with a long-term presentation (p = NS). All patients in the 0 CS group had single-vessel disease, and 9 (50%) with low CS had multivessel disease, with left main involvement in 1. Of the 27 patients with obstructive CAD on multidetector computed tomography, invasive coronary angiography confirmed these findings in 21 of 23 patients (positive predictive value 91%), and 16 (76%) of them (6.9% of the 0 CS and low CS groups) underwent a myocardial revascularization procedure after invasive coronary angiographic concordance. In conclusion, despite the high known negative predictive value of CS for coronary events, a low and even 0 CS does not exclude clinically important obstructive CAD in patients undergoing investigation of an acute or long-term chest pain syndrome. Contrast-enhanced multidetector computed tomography should be the noninvasive computed tomographic test of choice when possible in these patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17293187     DOI: 10.1016/j.amjcard.2006.08.060

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  49 in total

Review 1.  Prognostic utility of coronary computed tomographic angiography.

Authors:  Yuka Otaki; Daniel S Berman; James K Min
Journal:  Indian Heart J       Date:  2013-04-12

2.  The absence of coronary calcification does not exclude obstructive coronary artery disease or the need for revascularization in patients referred for conventional coronary angiography.

Authors:  Ilan Gottlieb; Julie M Miller; Armin Arbab-Zadeh; Marc Dewey; Melvin E Clouse; Leonardo Sara; Hiroyuki Niinuma; David E Bush; Narinder Paul; Andrea L Vavere; John Texter; Jeffery Brinker; João A C Lima; Carlos E Rochitte
Journal:  J Am Coll Cardiol       Date:  2010-02-16       Impact factor: 24.094

3.  Coronary artery calcium screening: current status and recommendations from the European Society of Cardiac Radiology and North American Society for Cardiovascular Imaging.

Authors:  Matthijs Oudkerk; Arthur E Stillman; Sandra S Halliburton; Willi A Kalender; Stefan Möhlenkamp; Cynthia H McCollough; Rozemarijn Vliegenthart; Leslee J Shaw; William Stanford; Allen J Taylor; Peter M A van Ooijen; Lewis Wexler; Paolo Raggi
Journal:  Eur Radiol       Date:  2008-07-24       Impact factor: 5.315

4.  Multislice computed tomography evaluation of cardiac syndrome X patients.

Authors:  Dhakshinamurthy Vijay Anand
Journal:  J Nucl Cardiol       Date:  2008 Sep-Oct       Impact factor: 5.952

Review 5.  Role of cardiac computed tomography and magnetic resonance imaging in the evaluation of acute chest pain in the emergency department.

Authors:  Ali Salah; David J Moliterno; Roger Humphries; Mushabbar A Syed
Journal:  Int J Cardiovasc Imaging       Date:  2007-09-12       Impact factor: 2.357

6.  Coronary Calcium Scoring as the Gate Keeper for Stress Myocardial Perfusion Imaging: Antagonist.

Authors:  Shane M Ruckel; Martha Gulati
Journal:  J Nucl Cardiol       Date:  2017-01-31       Impact factor: 5.952

7.  Incremental prognostic value of coronary computed tomographic angiography over coronary artery calcium score for risk prediction of major adverse cardiac events in asymptomatic diabetic individuals.

Authors:  James K Min; Troy M Labounty; Millie J Gomez; Stephan Achenbach; Mouaz Al-Mallah; Matthew J Budoff; Filippo Cademartiri; Tracy Q Callister; Hyuk-Jae Chang; Victor Cheng; Kavitha M Chinnaiyan; Benjamin Chow; Ricardo Cury; Augustin Delago; Allison Dunning; Gudrun Feuchtner; Martin Hadamitzky; Jorg Hausleiter; Philipp Kaufmann; Yong-Jin Kim; Jonathon Leipsic; Fay Y Lin; Erica Maffei; Gilbert Raff; Leslee J Shaw; Todd C Villines; Daniel S Berman
Journal:  Atherosclerosis       Date:  2013-10-29       Impact factor: 5.162

8.  Usefulness of coronary calcium scoring to myocardial perfusion SPECT in the diagnosis of coronary artery disease in a predominantly high risk population.

Authors:  Jeroen Schaap; Robert M Kauling; S Matthijs Boekholdt; Martijn C Post; Jan A Van der Heyden; Thom L de Kroon; H Wouter van Es; Benno J W M Rensing; J Fred Verzijlbergen
Journal:  Int J Cardiovasc Imaging       Date:  2012-08-18       Impact factor: 2.357

9.  Subclinical coronary artery disease as detected by coronary computed tomography angiography in an asymptomatic population.

Authors:  Sahmin Lee; Eue-Keun Choi; Hyuk-Jae Chang; Chi-Hoon Kim; Won-Woo Seo; Jin Joo Park; Choi Sang Il; Eun-Ju Chun; Sung-A Chang; Hyung-Kwan Kim; Yong-Jin Kim; Bon-Kwon Koo; Dong-Joo Choi; Byunghee Oh
Journal:  Korean Circ J       Date:  2010-09-30       Impact factor: 3.243

10.  Assessment of coronary artery calcium by using volumetric 320-row multi-detector computed tomography: comparison of 0.5 mm with 3.0 mm slice reconstructions.

Authors:  Noortje van der Bijl; Paul W de Bruin; Jacob Geleijns; Jeroen J Bax; Joanne D Schuijf; Albert de Roos; Lucia J M Kroft
Journal:  Int J Cardiovasc Imaging       Date:  2010-01-14       Impact factor: 2.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.